{"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"18"},{"groupId":"BG004","value":"33"}],"units":"Participants"}],"groups":[{"description":"Phase 1: Ixazomib 4.0 mg, Idasanutlin 100 mg, and Dexamethasone 40 mg","id":"BG000","title":"Phase 1: Dose Level 0"},{"description":"Phase 1: Ixazomib 4.0 mg, Idasanutlin 200 mg, and Dexamethasone 40 mg","id":"BG001","title":"Phase 1: Dose Level 1"},{"description":"Phase 1: Ixazomib 4.0 mg, Idasanutlin 250 mg, and Dexamethasone 40 mg","id":"BG002","title":"Phase 1: Dose Level 2"},{"description":"Phase 2: Ixazomib 4.0 mg, Idasanutlin 200 mg, and Dexamethasone 40 mg","id":"BG003","title":"Phase 2: Dose Level 1"},{"description":"Total of all reporting groups","id":"BG004","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"6.60","value":"67.3"},{"groupId":"BG001","spread":"8.69","value":"60.9"},{"groupId":"BG002","spread":"12.03","value":"63.0"},{"groupId":"BG003","spread":"7.65","value":"65.0"},{"groupId":"BG004","spread":"8.19","value":"64.2"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"5"},{"groupId":"BG004","value":"8"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"13"},{"groupId":"BG004","value":"25"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"2"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"16"},{"groupId":"BG004","value":"31"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"2"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"4"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"15"},{"groupId":"BG004","value":"27"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"11"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"10"},{"groupId":"BG004","value":"19"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"3"}]}],"title":"2"}],"description":"ECOG = 0: Fully active, able to carry on all pre-disease performance without restriction.\\> ECOG = 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.\\> ECOG = 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours.\\> ECOG = 0 is better. ECOG = 2 is worse.","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG Performance Status (PS)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"14"},{"groupId":"BG004","value":"28"}]}],"title":"High Risk"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"5"}]}],"title":"Standard Risk"}],"description":"Standard Risk: All others including: Trisomies t(11;14)d t(6;14).\\> High Risk: t(4;14) t(14;16) t(14;20) Del 17p 53 mutation Gain 1q RISS Stage 3 High Plasma Cell S-phasec GEP: High risk signature.\\> Standard Risk is best, High Risk is worst.","paramType":"COUNT_OF_PARTICIPANTS","title":"Mayo Clinic Stratification for Myeloma and Risk-Adapted Therapy (mSMART)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"15"}]}],"title":"Stage I"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"5"},{"groupId":"BG004","value":"8"}]}],"title":"Stage II"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"5"}]}],"title":"Stage III"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"4"}]}],"title":"Unknown"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"}]}],"title":"Missing"}],"description":"Stage I: Sβ2M \\< 3.5 mg/L; serum albumin ≥ 3.5 g/dL\\> Stage II: Sβ2M \\< 3.5 mg/L; serum albumin \\< 3.5 g/dL; or β2M 3.5 to 5.5 mg/L, irrespective of serum albumin\\> Stage III: Sβ2M \\> 5.5 mg/L\\> Stage I is best, Stage III is worst.","paramType":"COUNT_OF_PARTICIPANTS","title":"What was the International Staging System myeloma stage?","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"3"}]}],"title":"I"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"14"},{"groupId":"BG004","value":"25"}]}],"title":"II"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"5"}]}],"title":"III"}],"description":"Stage I: Sβ2M \\< 3.5 mg/l, Serum albumin ≥ 3.5 g/dl, Standard-risk chromosomal abnormalities (CA) by iFISH, Normal LDH\\> Stage II: Not R-ISS stage I or III\\> Stage III: Sβ2M ≥ 5.5 mg/L and either, High-risk CA by FISH\\> OR, High LDH\\> Stage I is best, Stage III is worst","paramType":"COUNT_OF_PARTICIPANTS","title":"Revised International Staging System","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.24","value":"0.8"},{"groupId":"BG001","spread":"0.60","value":"1.1"},{"groupId":"BG002","spread":"0.19","value":"0.9"},{"groupId":"BG003","spread":"0.53","value":"1.2"},{"groupId":"BG004","spread":"0.49","value":"1.1"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Serum Creatinine (mg/dL)","unitOfMeasure":"mg/dL"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"43.94","value":"201.3"},{"groupId":"BG001","spread":"162.89","value":"198.7"},{"groupId":"BG002","spread":"239.56","value":"349.0"},{"groupId":"BG003","spread":"119.45","value":"259.6"},{"groupId":"BG004","spread":"144.49","value":"249.5"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Serum LDH (U/L)","unitOfMeasure":"(U/L)"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"5"}]}],"title":"Serum M-spike >= 1 g/dL and urine M-spike >= 200 mg/24 hours"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"11"}]}],"title":"Serum M-spike >= 1 g/dL only"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"8"},{"groupId":"BG004","value":"8"}]}],"title":"Urine M-spike >= 200 mg/24 hours only"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"9"}]}],"title":"Serum immunoglobulin free light chain >= 10 mg/dL"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Parameter for response","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"16"}]}],"title":"SPEP measurement"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"12"},{"groupId":"BG004","value":"17"}]}],"title":"Missing"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"(If serum M-spike), parameter followed for serum M-spike","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"15"},{"groupId":"BG004","value":"24"}]}],"title":"Relapsed"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"9"}]}],"title":"Refractory"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Disease category","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"14"},{"groupId":"BG004","value":"26"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"7"}]}],"title":"No"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Prior transplant related to this cancer","unitOfMeasure":"Participants"}]}